DB
NERV icon

Dmitry Balyasny’s Minerva Neurosciences NERV Stock Holding History

Dmitry Balyasny’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6M Sell
4,257,000
-1,600
-0% -$8.68K 0.03% 641
2026
Q1 		$25.7M Buy
+4,258,600
New +$24.4M 0.03% 590

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM

Dmitry Balyasny's NERV Position: Q2 2026 in Review

Dmitry Balyasny reduced its Minerva Neurosciences (NERV) stake by 0.04% in Q2 2026, selling an estimated $8.68K and leaving 4,257,000 shares worth $23.6M. The position accounts for 0.03% of the portfolio, ranked #641.

Dmitry Balyasny first reported a position in NERV in Q1 2026 and has held it in 2 quarters since. The position peaked at $25.7M in Q1 2026. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Dmitry Balyasny held 4,257,000 shares of Minerva Neurosciences worth $23.6M as of Q2 2026.
  • Dmitry Balyasny sold 1,600 Minerva Neurosciences shares in Q2 2026, an estimated $8.68K.
  • Minerva Neurosciences made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #641 holding.
  • Dmitry Balyasny first reported a position in Minerva Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • Dmitry Balyasny's Minerva Neurosciences position peaked at $25.7M in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.